GlassScriptPhysician profile
Aditya Srinivasan
NPI 1619592938
$2,862.39
in general payments reported to CMS, 2019-2025
16 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.52 · 2021: $150 · 2022: $131 · 2024: $1,446 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,523 · Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,523.25 |
| Food and Beverage | $1,037.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,390.63 | 2020-2025 | Tactra, General - Erectile Dysfunction, Ams 700 |
| Intuitive Surgical, INC. | $711.73 | 2025 | |
| Coloplast Corp | $319.85 | 2021-2024 | |
| Calyxo, INC. | $83.81 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $64.30 | 2025 | |
| Procept Biorobotics Corporation | $50.46 | 2025 | |
| Janssen Biotech, INC. | $38.16 | 2025 | Erleada |
| Ethicon US, LLC | $33.78 | 2021 | |
| Silk Road Medical, INC. | $25.48 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Endo Pharmaceuticals INC. | $25.36 | 2021 | |
| Progenics Pharmaceuticals, INC. | $24.78 | 2025 | |
| Laborie Medical Technologies Corp. | $19.73 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $19.54 | 2025 | |
| Ferring Pharmaceuticals INC. | $19.48 | 2025 | Adstiladrin |
| Tolmar, INC. | $19.22 | 2025 | Jatenzo, Eligard |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $16.08 | 2025 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Srinivasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.